Clinical trial

CRP, Procalcitonin and Pro-BNP as Diagnostic and Prognostic Markers in AECOPD

NCT06514599

Drugs and interventions used in this trial

0 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

No interventions are currently published for this study in CureCurrent. View the original registry record below.

Study at a glance

Registry-backed

CRP, Procalcitonin and Pro-BNP as Diagnostic and Prognostic Markers in AECOPD

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2023-02-15

PhaseN/A

Conditions

COPD Exacerbation Acuteunresolved

Interventions

Sponsors & collaborators

Kanuni Sultan Suleyman Training and Research Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06514599 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.